Works matching IS 17762596 AND DT 2022 AND VI 17 AND IP 1

Results: 12

Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 53, doi. 10.1007/s11523-021-00862-x

By:

Lin, Lishi;
Smit, Egbert F.;
de Langen, Adrianus J.;
van Balen, Dorieke E. M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 43, doi. 10.1007/s11523-021-00865-8

By:

Sisi, Monia;
Fusaroli, Michele;
De Giglio, Andrea;
Facchinetti, Francesco;
Ardizzoni, Andrea;
Raschi, Emanuel;
Gelsomino, Francesco

Publication type:

Article

Correction to: Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features.

Published in:

2022

By:

Shirley, Matt

Publication type:

Correction Notice

Correction to: Durvalumab: A Review in Extensive-Stage SCLC.

Published in:

2022

By:

Al-Salama, Zaina T.

Publication type:

Correction Notice

Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 61, doi. 10.1007/s11523-021-00861-y

By:

Mollica, Veronica;
Santoni, Matteo;
Matrana, Marc R.;
Basso, Umberto;
De Giorgi, Ugo;
Rizzo, Alessandro;
Maruzzo, Marco;
Marchetti, Andrea;
Rosellini, Matteo;
Bleve, Sara;
Maslov, Diana;
Tawagi, Karine;
Philon, Ernest;
Blake, Zoe;
Massari, Francesco

Publication type:

Article

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1007/s11523-021-00859-6

By:

Tu, Hai-Yan;
Feng, Jifeng;
Shi, Meiqi;
Zhao, Jun;
Wang, Yuyan;
Chang, Jianhua;
Wang, Jialei;
Cheng, Ying;
Zhu, Jing;
Tan, Eng-Huat;
Li, Kai;
Zhang, Yiping;
Lee, Victor;
Yang, Cheng-Ta;
Su, Wu-Chou;
Lam, David Chi-Leung;
Srinivasa, B. J.;
Rajappa, Senthil;
Ho, Ching-Liang;
Lam, Kwok Chi

Publication type:

Article

Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 25, doi. 10.1007/s11523-021-00860-z

By:

Waterhouse, David;
Iadeluca, Laura;
Sura, Sneha;
Wilner, Keith;
Emir, Birol;
Krulewicz, Stan;
Espirito, Janet;
Bartolome, Lauren

Publication type:

Article

MYL-1402O: A Bevacizumab Biosimilar.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 85, doi. 10.1007/s11523-021-00858-7

By:

Lee, Arnold

Publication type:

Article

Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 69, doi. 10.1007/s11523-021-00857-8

By:

Shirley, Matt

Publication type:

Article

Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry.

Published in:

Targeted Oncology, 2022, v. 17, n. 1, p. 35, doi. 10.1007/s11523-021-00856-9

By:

Alawawdeh, Anas;
Piantadosi, Cynthia;
Townsend, Amanda Rose;
Karapetis, Christos Stelios;
Padbury, Rob;
Roy, Amitesh Chandra;
Moore, James;
Maddern, Guy;
Roder, David;
Smith, Annabelle;
Price, Timothy Jay

Publication type:

Article

A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.

Published in:

2022

By:

Shimizu, Toshio;
Kuboki, Yasutoshi;
Lin, Chia-Chi;
Yonemori, Kan;
Yanai, Tomoko;
Faller, Douglas V.;
Dobler, lwona;
Gupta, Neeraj;
Sedarati, Farhad;
Kim, Kyu-pyo

Publication type:

journal article

Correction to: Niraparib: A Review in First-Line Maintenance Therapy in Advanced Ovarian Cancer.

Published in:

2022

By:

Lee, Arnold

Publication type:

Correction Notice